The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer

Author:

Wang Eric1,Kawaoka Shinpei1,Roe Jae-Seok1,Shi Junwei12,Hohmann Anja F1,Xu Yali12,Bhagwat Anand S13,Suzuki Yutaka4,Kinney Justin B12,Vakoc Christopher R1

Affiliation:

1. Cold Spring Harbor Laboratory, New York, United States

2. Molecular and Cellular Biology Program, Stony Brook University, New York, United States

3. Medical Scientist Training Program, Stony Brook University, New York, United States

4. Department of Medical Genome Sciences, University of Tokyo, Kashiwa, Japan

Abstract

Most mammalian transcription factors (TFs) and cofactors occupy thousands of genomic sites and modulate the expression of large gene networks to implement their biological functions. In this study, we describe an exception to this paradigm. TRIM33 is identified here as a lineage dependency in B cell neoplasms and is shown to perform this essential function by associating with a single cis element. ChIP-seq analysis of TRIM33 in murine B cell leukemia revealed a preferential association with two lineage-specific enhancers that harbor an exceptional density of motifs recognized by the PU.1 TF. TRIM33 is recruited to these elements by PU.1, yet acts to antagonize PU.1 function. One of the PU.1/TRIM33 co-occupied enhancers is upstream of the pro-apoptotic gene Bim, and deleting this enhancer renders TRIM33 dispensable for leukemia cell survival. These findings reveal an essential role for TRIM33 in preventing apoptosis in B lymphoblastic leukemia by interfering with enhancer-mediated Bim activation.

Funder

National Cancer Center (NCC)

Alex's Lemonade Stand Foundation for Childhood Cancer

Burroughs Wellcome Fund (BWF)

Japan Society for the Promotion of Science (JSPS)

SASS Foundation for Medical Research

National Cancer Institute (NCI)

Boehringer Ingelheim Fonds (BIF)

V Foundation for Cancer Research

National Institutes of Health (NIH)

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3